Free Daily Analysis

Stock Trend Analysis Report

Prepared for you on Wednesday, December 1, 2021.

Loncar Cancer Immunotherapy ETF (NASDAQ:CNCR)

Long-Term Downtrend (-90) - CNCR is in a strong downtrend that is likely to continue. While CNCR is showing intraday strength, it remains in the confines of a bearish trend. Traders should use caution and set stops.

Is it time to buy, sell, or avoid CNCR?

MarketClub looks at technical strength and momentum to determine if the timing is right for CNCR.

Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.

NASDAQ_CNCR
Open High Low CNCR Price Change
27.250 27.275 27.230 27.275 +0.495
Entry Signal

MarketClub’s Trade Triangles for CNCR

long term down The long-term trend has been DOWN since Aug 17th, 2021 at 28.12

intermediate term down The intermediate-term trend has been DOWN since Nov 16th, 2021 at 28.45

short term down The short-term trend has been DOWN since Nov 5th, 2021 at 29.55

Smart Scan Analysis for CNCR

Based on our trend formula, CNCR is rated as a -90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).

-90
Smart Scan Analysis for CNCR
Strong Downtrend Sideways Strong Uptrend
Open High Low Price Change
27.250 27.275 27.230 27.275 +0.495
Prev. Close Volume Bid Ask Time
26.780 1315 2021-12-01 11:31:46
Year High32.32Year High Date2018-03-13
Year Low19.1252Year Low Date2018-10-29
52wk High35.81852wk High Date2021-02-08
52wk Low26.55552wk Low Date2021-11-30
Average Volume4,908Shares Outstanding100
Market Cap34MVolatility39.81
Get a free daily analysis and signals for Loncar Cancer Immunotherapy ETF (CNCR) - Request Your Free Report.